Skip to main content
Top
Published in: Immunity & Ageing 1/2009

Open Access 01-12-2009 | Research

Phenotype of apoptotic lymphocytes in children with Down syndrome

Authors: Solaf M Elsayed, Ghada M Elsayed

Published in: Immunity & Ageing | Issue 1/2009

Login to get access

Abstract

Background

Down syndrome (DS) is the most common and best-known chromosomal disorder and is associated with several other pathologic conditions including immunodeficiency which makes a significant contribution to morbidity and mortality. Various immunological theories and observations to explain the predisposition of individuals with DS to various infections have been published, one of which is increased apoptotic cells.

Aim

The aim of this study was to identify the effect of apoptosis on both types of cells of specific immune response (T and B lymphocytes) in children with DS using Annexin V staining of phosphatidyserine (PS) as a specific marker of early apoptosis.

Subjects and methods

The study included 17 children with karyotypically ascertained DS (7 males and 10 females). Their ages ranged from 4 months to 14 years with mean age of 5.7 ± 4.35 years. Seventeen age and sex matched healthy children were included in the study as controls. Patients or controls with infections were excluded from the study. Complete blood picture, immunophenotyping, analysis of apoptosis using Annexin V was done at National cancer Institute to all children included in this study.

Results

Although CBC, differential count, relative and absolute number of CD3+ and CD16+ did not show significant differences between DS children and control group, the relative and the absolute size of apoptotic CD3+ T lymphocytes, and the relative size of apoptotic CD19+ B lymphocytes were significantly higher in DS children than in controls. On the other hand, no significant difference was detected as regards the absolute size of CD19+ B lymphocytes in DS children and in controls

Conclusion

our finding of increased early apoptotic cells (especially T cells) in DS children may emphasize the fact that the function of cells- and not their number- is main mechanism responsible for the impairment of the immune system in DS children and may further add to the known fact that cellular immunity is more severely affected than humoral immunity in these children. Further studies on apoptotic cellular phenotype in larger number of DS are needed
Appendix
Available only for authorised users
Literature
1.
go back to reference Cuadrado E, Barrena MJ: Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system?. Clin Immunol Immunopathol. 1996, 78: 209-14. 10.1006/clin.1996.0031.CrossRefPubMed Cuadrado E, Barrena MJ: Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system?. Clin Immunol Immunopathol. 1996, 78: 209-14. 10.1006/clin.1996.0031.CrossRefPubMed
2.
go back to reference Nespoli L, Burgio GR, Ugazio AG, Maccario R: Immunological features of Down's syndrome: a review. J Intellect Disabil Res. 1993, 37: 543-51.CrossRefPubMed Nespoli L, Burgio GR, Ugazio AG, Maccario R: Immunological features of Down's syndrome: a review. J Intellect Disabil Res. 1993, 37: 543-51.CrossRefPubMed
3.
go back to reference Cossariza A, Monti D, Montanani G, Ortolani C, Masi M, Zannoti M, Franceschi C: Precocious aging of the immune system in Down syndrome: alteration of B-lymphocyte, T lymphocytes subsets, and cells with natural killer markers. Am J Med Genet Suppl. 1990, 7: 213-8. 10.1002/ajmg.1320370743. Cossariza A, Monti D, Montanani G, Ortolani C, Masi M, Zannoti M, Franceschi C: Precocious aging of the immune system in Down syndrome: alteration of B-lymphocyte, T lymphocytes subsets, and cells with natural killer markers. Am J Med Genet Suppl. 1990, 7: 213-8. 10.1002/ajmg.1320370743.
4.
go back to reference Licastro F, Melotti C, Parente R, Davis LJ, Chiricolo M, Zannoti M, Barboni F: Derangement of non-specific immunity in Down syndrome subjects: low leukocyte chemiluminescence activity after phagocytic activation. Am J Med Genet Suppl. 1990, 7: 242-6. 10.1002/ajmg.1320370749.PubMed Licastro F, Melotti C, Parente R, Davis LJ, Chiricolo M, Zannoti M, Barboni F: Derangement of non-specific immunity in Down syndrome subjects: low leukocyte chemiluminescence activity after phagocytic activation. Am J Med Genet Suppl. 1990, 7: 242-6. 10.1002/ajmg.1320370749.PubMed
5.
go back to reference Loh RK, Harth SC, Thong YH, Ferrante A: Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome. Pediatr Infect Dis J. 1990, 9: 547-51.CrossRefPubMed Loh RK, Harth SC, Thong YH, Ferrante A: Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome. Pediatr Infect Dis J. 1990, 9: 547-51.CrossRefPubMed
6.
go back to reference Lockitch G, Singh VK, Puterman ML, Godolphin WJ, Sheps S, Tingle AJ: Age related changes in humoral and cell mediated immunity in Down syndrome children living at home. Pediatr Res. 1987, 22: 536-40. 10.1203/00006450-198711000-00013.CrossRefPubMed Lockitch G, Singh VK, Puterman ML, Godolphin WJ, Sheps S, Tingle AJ: Age related changes in humoral and cell mediated immunity in Down syndrome children living at home. Pediatr Res. 1987, 22: 536-40. 10.1203/00006450-198711000-00013.CrossRefPubMed
7.
go back to reference Martin GM: genetic syndromes in man with potential relevance to the pathophysiology of ging. Genetic effects of aging. Birth defects. Edited by: Bergsma D, Harrison DE. 1978, New York, NY, Liss, for the National foundation-March of Dimes, 14: 5- Martin GM: genetic syndromes in man with potential relevance to the pathophysiology of ging. Genetic effects of aging. Birth defects. Edited by: Bergsma D, Harrison DE. 1978, New York, NY, Liss, for the National foundation-March of Dimes, 14: 5-
8.
go back to reference Busciglio J, Yankner BA: Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 1995, 378: 776-9. 10.1038/378776a0.CrossRefPubMed Busciglio J, Yankner BA: Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 1995, 378: 776-9. 10.1038/378776a0.CrossRefPubMed
9.
go back to reference Yasui K, Shinozaki K, Nakazwa T, Agemastu K, Komiyama A: Presenility of granulocytes in Down syndrome individuals. Am J Med Genet. 1999, 84: 406-12. 10.1002/(SICI)1096-8628(19990611)84:5<406::AID-AJMG4>3.0.CO;2-4.CrossRefPubMed Yasui K, Shinozaki K, Nakazwa T, Agemastu K, Komiyama A: Presenility of granulocytes in Down syndrome individuals. Am J Med Genet. 1999, 84: 406-12. 10.1002/(SICI)1096-8628(19990611)84:5<406::AID-AJMG4>3.0.CO;2-4.CrossRefPubMed
10.
go back to reference Antonucci A, Baldassarre A, Franco DG, Stuppia L, Palka G: Detection of apoptosis in peripheral blood cells of 31 subjects affected by Down syndrome before and after zinc therapy. Ultrastructural pathology. 1997, 21: 449-52. 10.3109/01913129709021944.CrossRefPubMed Antonucci A, Baldassarre A, Franco DG, Stuppia L, Palka G: Detection of apoptosis in peripheral blood cells of 31 subjects affected by Down syndrome before and after zinc therapy. Ultrastructural pathology. 1997, 21: 449-52. 10.3109/01913129709021944.CrossRefPubMed
11.
go back to reference Corsi MM, Ponti W, Venditti A, Ferrara F, Baldo C, Chiappelli M, Licastro F: Proapoptotic activated T-cells in the blood of children with Down syndrome: Relationship with dietary antigens and intestinal alterations. Int J Tissue React. 2003, 25: 117-25.PubMed Corsi MM, Ponti W, Venditti A, Ferrara F, Baldo C, Chiappelli M, Licastro F: Proapoptotic activated T-cells in the blood of children with Down syndrome: Relationship with dietary antigens and intestinal alterations. Int J Tissue React. 2003, 25: 117-25.PubMed
12.
go back to reference De Hingh YC, Vossen VD, Gemen EF, Mulder AB, Hop WCJ, Brus F, Vries ED: Intrensic abnormalities of lymphocyte counts in children with Down syndrome. J pediatr. 2005, 147: 744-7. 10.1016/j.jpeds.2005.07.022.CrossRefPubMed De Hingh YC, Vossen VD, Gemen EF, Mulder AB, Hop WCJ, Brus F, Vries ED: Intrensic abnormalities of lymphocyte counts in children with Down syndrome. J pediatr. 2005, 147: 744-7. 10.1016/j.jpeds.2005.07.022.CrossRefPubMed
13.
go back to reference Koopamn G, Reutelingsper CPM, Kuijten GAM, Keehnen RMJ, Pals ST, Vanores MHJ: Annexin V for flow cytometric detection of phosphatedylserine expression on B cells undergoing apoptosis. Blood. 1994, 84: 1415-20. Koopamn G, Reutelingsper CPM, Kuijten GAM, Keehnen RMJ, Pals ST, Vanores MHJ: Annexin V for flow cytometric detection of phosphatedylserine expression on B cells undergoing apoptosis. Blood. 1994, 84: 1415-20.
14.
go back to reference Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay of apoptosis. Flow cytometry detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J immunol Methods. 1995, 184: 39-51. 10.1016/0022-1759(95)00072-I.CrossRefPubMed Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay of apoptosis. Flow cytometry detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J immunol Methods. 1995, 184: 39-51. 10.1016/0022-1759(95)00072-I.CrossRefPubMed
15.
go back to reference Licastro F, Chiricolo M, Mocchegiani E, Fabris N, Zannoti M, Beltrandi E, Mancini R, Parente R, Arena G, Masi M: Oral zinc supplementation in Down's syndrome subjects decreased infections and normalized some humoral and cellular immune parameters. J Intellect Disabil Res. 1994, 38: 149-62.CrossRefPubMed Licastro F, Chiricolo M, Mocchegiani E, Fabris N, Zannoti M, Beltrandi E, Mancini R, Parente R, Arena G, Masi M: Oral zinc supplementation in Down's syndrome subjects decreased infections and normalized some humoral and cellular immune parameters. J Intellect Disabil Res. 1994, 38: 149-62.CrossRefPubMed
16.
go back to reference Larocca LM, Piantelli M, Valitutti S, Castellino F, Maggiano N, Musiani P: Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). Clin Immunol Immunopathol. 1988, 49: 175-86. 10.1016/0090-1229(88)90108-0.CrossRefPubMed Larocca LM, Piantelli M, Valitutti S, Castellino F, Maggiano N, Musiani P: Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). Clin Immunol Immunopathol. 1988, 49: 175-86. 10.1016/0090-1229(88)90108-0.CrossRefPubMed
17.
go back to reference Ugazio AG, Maccario R, Notaangelo LD, Burgio GR: Immunology of Down syndrome; A review. Am J Med Genet. 1990, 204-12. 10.1002/ajmg.1320370742. Suppl Ugazio AG, Maccario R, Notaangelo LD, Burgio GR: Immunology of Down syndrome; A review. Am J Med Genet. 1990, 204-12. 10.1002/ajmg.1320370742. Suppl
18.
go back to reference Roat E, Prada N, Ferraresi R, Giovenzana C, Nasi M, Troiano L, Pinti M, Nemes E, Lugli E, Biagioni O, Mariotti M, Ciacci L, Consolo U, Balli F, Cossarizza A: Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome. FEBS Lett. 2007, 581: 521-5. 10.1016/j.febslet.2006.12.058.CrossRefPubMed Roat E, Prada N, Ferraresi R, Giovenzana C, Nasi M, Troiano L, Pinti M, Nemes E, Lugli E, Biagioni O, Mariotti M, Ciacci L, Consolo U, Balli F, Cossarizza A: Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome. FEBS Lett. 2007, 581: 521-5. 10.1016/j.febslet.2006.12.058.CrossRefPubMed
Metadata
Title
Phenotype of apoptotic lymphocytes in children with Down syndrome
Authors
Solaf M Elsayed
Ghada M Elsayed
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Immunity & Ageing / Issue 1/2009
Electronic ISSN: 1742-4933
DOI
https://doi.org/10.1186/1742-4933-6-2

Other articles of this Issue 1/2009

Immunity & Ageing 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.